Along these lines, intracerebral delivery of IL-1 receptor antagonist (IL-1ra) restrains hippocampal inflammation, synaptic dysfunction and cognitive impairment, indicating that IL-1β mediates obesity-associated deterioration of hippocampal function [236,239]. Here, IL1B is linked to obesity disorder.